GlobeNewswire: India Globalization Capital Contains the last 10 of 116 releaseshttp://www.globenewswire.com/External?Length=42024-03-28T08:18:01ZGlobeNewswirehttp://www.globenewswire.com/External?Length=4newsdesk@globenewswire.com (NewsDesk)https://www.globenewswire.com/news-release/2018/06/21/1528174/0/en/IGC-Announces-Financial-Results-for-Fiscal-Year-Ended-March-31-2018.html?f=22&fvtc=4&fvtv=17221IGC Announces Financial Results for Fiscal Year Ended March 31, 20182018-06-21T21:38:14Z<![CDATA[BETHESDA, Md., June 21, 2018 (GLOBE NEWSWIRE) -- India Globalization Capital, Inc. (NYSE American:IGC) announces financial results for the fiscal year ended March 31, 2018.]]>https://www.globenewswire.com/news-release/2018/03/12/1420490/0/en/India-Globalization-Capital-Appoints-Carrolee-Barlow-MD-PhD-as-Advisor-to-Help-Develop-Cannabis-Related-Products-for-Treating-Various-End-Points-of-Parkinson-s-Disease-and-Movement.html?f=22&fvtc=4&fvtv=17221India Globalization Capital Appoints Carrolee Barlow, MD, PhD as Advisor to Help Develop Cannabis Related Products for Treating Various End Points of Parkinson’s Disease and Movement Disorders (PDMD)2018-03-12T12:00:00Z<![CDATA[BETHESDA, Md., March 12, 2018 (GLOBE NEWSWIRE) -- India Globalization Capital, Inc. (NYSE American:IGC) today announces that Carrolee Barlow, MD, PhD has been appointed to the Company as an Advisor to help develop solutions and treatments for Parkinson’s disease utilizing cannabis related formulations. Dr. Barlow is a renowned expert in neuroscience & neurodegeneration and is currently the CEO of the Parkinson’s Institute and Clinical Center.]]>https://www.globenewswire.com/news-release/2018/03/01/1402123/0/en/India-Globalization-Capital-Partners-with-Parkinson-s-Institute-and-Clinical-Center-to-Develop-Cannabis-Related-Products-for-Treating-Various-End-Points-of-Parkinson-s-Disease-and-.html?f=22&fvtc=4&fvtv=17221India Globalization Capital Partners with Parkinson’s Institute and Clinical Center to Develop Cannabis Related Products for Treating Various End Points of Parkinson’s Disease and Movement Disorders (PDMD)2018-03-01T13:00:00Z<![CDATA[BETHESDA, Md., March 01, 2018 (GLOBE NEWSWIRE) -- India Globalization Capital, Inc. (NYSE American:IGC) today announces that it has signed a Joint Development and Services Agreement with the prestigious Parkinson’s Institute and Clinical Center of Sunnyvale, California.]]>https://www.globenewswire.com/news-release/2018/02/20/1361994/0/en/IGC-Announces-Third-Quarter-Financial-Results-Advances-Hyalolex-to-Commercialization-Stage.html?f=22&fvtc=4&fvtv=17221IGC Announces Third Quarter Financial Results Advances Hyalolex to Commercialization Stage2018-02-20T14:14:05Z<![CDATA[BETHESDA, Md., Feb. 20, 2018 (GLOBE NEWSWIRE) -- India Globalization Capital, Inc. (NYSE:IGC) announced financial results for the third quarter ended December 31, 2017 for the fiscal year that ends March 31, 2018 (the “FYE2018 Q3”).]]>https://www.globenewswire.com/news-release/2018/02/12/1339013/0/en/India-Globalization-Capital-s-CEO-to-Speak-at-CEO-Healthcare-Symposium-in-NY-on-February-12-13.html?f=22&fvtc=4&fvtv=17221India Globalization Capital’s CEO to Speak at CEO Healthcare Symposium in NY on February 12 & 132018-02-12T13:00:00Z<![CDATA[BETHESDA, Md., Feb. 12, 2018 (GLOBE NEWSWIRE) -- India Globalization Capital, Inc. (NYSE-MKT:IGC) announced today that Ram Mukunda will be a speaker at the upcoming CEO Healthcare Symposium in New York on February 12 and February 13, 2018. His presentation will include commentary on the Company’s efforts in developing and commercializing cannabis–based pharmaceuticals including Hyalolex for Alzheimer’s disease.]]>https://www.globenewswire.com/news-release/2018/01/02/1277021/0/en/India-Globalization-Capital-Reports-Promising-Spatial-Memory-Results-in-Alzheimer-s-Study.html?f=22&fvtc=4&fvtv=17221India Globalization Capital Reports Promising Spatial Memory Results in Alzheimer’s Study2018-01-02T13:00:00Z<![CDATA[BETHESDA, Md., Jan. 02, 2018 (GLOBE NEWSWIRE) -- India Globalization Capital, Inc. (NYSE-MKT:IGC) provides compelling in vivo data compiled from genetically engineered mice to mimic Alzheimer’s shows marked improvement in spatial memory.]]>https://www.globenewswire.com/news-release/2017/12/26/1274581/0/en/India-Globalization-Capital-to-use-Blockchain-to-Address-Issues-Specific-to-the-Medical-Cannabis-Industry.html?f=22&fvtc=4&fvtv=17221India Globalization Capital to use Blockchain to Address Issues Specific to the Medical Cannabis Industry2017-12-26T13:00:00Z<![CDATA[BETHESDA, Md., Dec. 26, 2017 (GLOBE NEWSWIRE) -- India Globalization Capital, Inc. (NYSE American:IGC), today announces that it will leverage its existing team of technology and healthcare experts to develop methods utilizing blockchain in areas such as product identification assurance (PIA). According to a recent study that was published in JAMA and detailed on www.pennmedicine.org, nearly 70% of all cannabidiol products sold online are either over or under labeled.]]>https://www.globenewswire.com/news-release/2017/12/18/1263290/0/en/IGC-Announces-Adjournment-of-Annual-Meeting-Voting-for-Proposals-Three-and-Four-to-Dec-29-2017.html?f=22&fvtc=4&fvtv=17221IGC Announces Adjournment of Annual Meeting Voting for Proposals Three and Four to Dec 29, 20172017-12-18T13:00:00Z<![CDATA[Seeks to Obtain a Quorum of Voting Stockholders Owning Shares as of October 5, 2017 Seeks to Obtain a Quorum of Voting Stockholders Owning Shares as of October 5, 2017]]>https://www.globenewswire.com/news-release/2017/12/14/1261985/0/en/India-Globalization-Capital-Provides-Update-on-Hyalolex-for-Alzheimer-s-Commercialization-Strategy.html?f=22&fvtc=4&fvtv=17221India Globalization Capital Provides Update on Hyalolex for Alzheimer’s Commercialization Strategy2017-12-14T13:00:00Z<![CDATA[BETHESDA, Md., Dec. 14, 2017 (GLOBE NEWSWIRE) -- India Globalization Capital, Inc. (NYSE American:IGC) today provides an update on corporate initiatives to launch its lead product for Alzheimer’s, Hyalolex, through licensed medical dispensaries in the U.S. Investors and interested parties are encouraged to visit www.Hyalolex.com for information on Alzheimer’s disease and research data related to our product formulation.]]>https://www.globenewswire.com/news-release/2017/12/07/1247432/0/en/India-Globalization-Capital-Launches-New-Corporate-Websites-Highlighting-Canna-Pharmaceutical-Compound-Portfolio.html?f=22&fvtc=4&fvtv=17221India Globalization Capital Launches New Corporate Websites Highlighting Canna-Pharmaceutical Compound Portfolio2017-12-07T13:00:00Z<![CDATA[BETHESDA, Md., Dec. 07, 2017 (GLOBE NEWSWIRE) -- India Globalization Capital, Inc. (NYSE American:IGC), today announced that it has launched two new websites to detail the Company’s cannabinoid pipeline for the indications of pain, seizures, eating disorders and Alzheimer’s. Investors are encouraged to visit www.igcpharma.com and www.Hyalolex.com for the latest information on IGC’s initiatives and development timeline.]]>